- FDA approved monoclonal antibodies approved for the first time in 2018
- Five candidates for FDA approval during Q4 2018, or Q1 2019
- Monoclonal antibodies in late stage clinical trials
- Emerging trends in antibody therapeutics
- The next generation of antibody therapeutics in the next 5-10 years
To download the exclusive report simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content.
Have any questions about the report or interested in sponsoring a future report? Email email@example.com.